SCHEMBL12411237

SCHEMBL12411237

CN(/C(=C/c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
AKR1C1 Q04828 1/20 0.46
ALDH1A1 P00352 4/20 0.44
MAPT P10636 4/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
AKR1C3 P42330 1/20 0.42
CYP2D6 P10635 1/20 0.42
MEN1 O00255 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
FAAH O00519 1/20 0.41
PHGDH O43175 1/20 0.41
MGLL Q99685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411239 0.82 KMT2A (0.51) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL2845203 0.82 AKR1C1 (0.45) KMT2AAKR1C1ALDH1A1MAPTLMNA
SCHEMBL20414312 0.82 KMT2A (0.51) KMT2AALDH1A1LMNAKDM4ERAB9A
SCHEMBL6031703 0.80 TRPM8 (0.48) KMT2AAKR1C1ALDH1A1MAPTLMNA
SCHEMBL9446229 0.80 TRPM8 (0.48) KMT2AAKR1C1ALDH1A1MAPTLMNA
SCHEMBL9446234 0.80 TRPM8 (0.48) KMT2AAKR1C1ALDH1A1MAPTLMNA
SCHEMBL9446228 0.78 ALDH1A1 (0.52) KMT2AAKR1C1ALDH1A1MTNR1AMTNR1B
SCHEMBL9446220 0.78 ALDH1A1 (0.52) KMT2AAKR1C1ALDH1A1MTNR1AMTNR1B
SCHEMBL7904469 0.78 ESR1 (0.45) KMT2AAKR1C1ALDH1A1MAPTGAA
SCHEMBL12411238 0.78 LMNA (0.48) KMT2AALDH1A1MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580990-B2 Gold catalyzed hydroamination of alkynes and allenes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-11-12 US disclosed
US-8580990-B2 Gold catalyzed hydroamination of alkynes and allenes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-11-12 US disclosed
US-20110166349-A1 GOLD CATALYZED HYDROAMINATION OF ALKYNES AND ALLENES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-07 US disclosed
US-20110166349-A1 GOLD CATALYZED HYDROAMINATION OF ALKYNES AND ALLENES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166349-A1 GOLD CATALYZED HYDROAMINATION OF ALKYNES AND ALLENES AOC3, AOC2, AOC1 KMT2A 984/4885AKR1C1 375/4885ALDH1A1 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.